Specifically, the median age of the TB derivation sample surpassed that of the validation sample (44 vs 31 years, P < 0.001), whereas less than one-third of lymphomatous effusions from the validation population had high pleural fluid ADA levels as compared to 100% of the derivation population. The gene discussed is ADA; the disease is tuberculosis.